Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Nov;31(11):1855–1858. doi: 10.1128/aac.31.11.1855

Predicted and measured aminoglycoside pharmacokinetic parameters in critically ill patients.

E Hassan 1, J D Ober 1
PMCID: PMC175054  PMID: 3435131

Abstract

We conducted a prospective study to determine whether predicted aminoglycoside pharmacokinetic parameters (based on population averages) correlate with measured values in critically ill patients. There was wide interpatient variability for all pharmacokinetic parameters. Only predicted and measured volumes of distribution (18.7 +/- 6.5 versus 22.9 +/- 7.7 liters [mean +/- standard deviation], respectively), with a mean of 0.32 +/- 0.09 liter/kg of dosing body weight, were significantly different. There were no relationships between pharmacokinetic parameters and documented infection, death, or intubation status. The results indicate that volume of distribution is commonly underestimated in intensive care unit patients, whereas elimination rates may be adequately predicted based on population averages. We therefore recommend that aminoglycoside volume of distribution estimates for intensive care unit patients take fluid and adipose excess into account and be based on 0.32 liter/kg rather than the usual 0.25 liter/kg.

Full text

PDF
1858

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chan R. A., Benner E. J., Hoeprich P. D. Gentamicin therapy in renal failure: a nomogram for dosage. Ann Intern Med. 1972 May;76(5):773–778. doi: 10.7326/0003-4819-76-5-773. [DOI] [PubMed] [Google Scholar]
  2. Hull J. H., Sarubbi F. A., Jr Gentamicin serum concentrations: pharmacokinetic predictions. Ann Intern Med. 1976 Aug;85(2):183–189. doi: 10.7326/0003-4819-85-2-183. [DOI] [PubMed] [Google Scholar]
  3. Kelman A. W., Thomson A. H., Whiting B., Bryson S. M., Steedman D. A., Mawer G. E., Samba-Donga L. A. Estimation of gentamicin clearance and volume of distribution in neonates and young children. Br J Clin Pharmacol. 1984 Nov;18(5):685–692. doi: 10.1111/j.1365-2125.1984.tb02530.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. King C. H., Creger R. J., Ellner J. J. Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs. Antimicrob Agents Chemother. 1985 Mar;27(3):285–290. doi: 10.1128/aac.27.3.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kreuzer F., Cain S. M. Regulation of the peripheral vasculature and tissue oxygenation in health and disease. Crit Care Clin. 1985 Nov;1(3):453–470. [PubMed] [Google Scholar]
  6. Majerus T. C., Caplan E. S. Predicting serum gentamicin levels in adult trauma patients. Clin Ther. 1980;3(4):316–328. [PubMed] [Google Scholar]
  7. Moore R. D., Lietman P. S., Smith C. R. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis. 1987 Jan;155(1):93–99. doi: 10.1093/infdis/155.1.93. [DOI] [PubMed] [Google Scholar]
  8. Moore R. D., Smith C. R., Lietman P. S. The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J Infect Dis. 1984 Mar;149(3):443–448. doi: 10.1093/infdis/149.3.443. [DOI] [PubMed] [Google Scholar]
  9. Niemiec P. W., Jr, Allo M. D., Miller C. F. Effect of altered volume of distribution on aminoglycoside levels in patients in surgical intensive care. Arch Surg. 1987 Feb;122(2):207–212. doi: 10.1001/archsurg.1987.01400140089012. [DOI] [PubMed] [Google Scholar]
  10. Ristuccia A. M., Cunha B. A. The aminoglycosides. Med Clin North Am. 1982 Jan;66(1):303–312. doi: 10.1016/s0025-7125(16)31462-6. [DOI] [PubMed] [Google Scholar]
  11. Sawchuk R. J., Zaske D. E., Cipolle R. J., Wargin W. A., Strate R. G. Kinetic model for gentamicin dosing with the use of individual patient parameters. Clin Pharmacol Ther. 1977 Mar;21(3):362–369. doi: 10.1002/cpt1977213362. [DOI] [PubMed] [Google Scholar]
  12. Sawchuk R. J., Zaske D. E. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients. J Pharmacokinet Biopharm. 1976 Apr;4(2):183–195. doi: 10.1007/BF01086153. [DOI] [PubMed] [Google Scholar]
  13. Summer W. R., Michael J. R., Lipsky J. J. Initial aminoglycoside levels in the critically ill. Crit Care Med. 1983 Dec;11(12):948–950. doi: 10.1097/00003246-198312000-00011. [DOI] [PubMed] [Google Scholar]
  14. Zaske D. E., Cipolle R. J., Strate R. G., Malo J. W., Koszalka M. F., Jr Rapid gentamicin elimination in obstetric patients. Obstet Gynecol. 1980 Nov;56(5):559–564. [PubMed] [Google Scholar]
  15. Zaske D. E., Sawchuk R. J., Gerding D. N., Strate R. G. Increased dosage requirements of gentamicin in burn patients. J Trauma. 1976 Oct;16(10):824–828. doi: 10.1097/00005373-197610000-00014. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES